Immunological Protection of Individuals Aged 3 to 25 Years Against Pertussis: Regional Cross-Sectional Study

Background. Recently, there has been an increase in the incidence of pertussis in unvaccinated, as well as vaccinated children and adults. The major risk group for pertussis are infants and children over 4 years of age due to gradual decrease in basic immunity. Objective. The aim of the study was to analyze postvaccinal immunity against pertussis in individuals aged 3 to 25 years in Krasnodar. Methods. The study was carried out in the period between July 2018 and October 2019 and included patients aged 3 to 25 years with completed (according to National Immunization Schedule) immunization against pertussis with no history of pertussis in the past. Postvaccinal immunity against pertussis in this sample was determined by the ratio of study participants with minimum protective antibodies titer to Bordetella pertussis (≥ 1:160). Results. The minimum protective antibody titer was revealed in 24 out of 76 participants. Distribution to age groups was the following: children aged 3 to 7 years — 2/28 (7%), 8 to 17 years — 13/22 (59%; p < 0.001, compared with the younger age group), ≥ 18 years — 9/26 (35%; p = 0.017). There was no postvaccinal immunity (no antibodies detected) in 6 (21%), 1 (5%) and 4 (15%) participants, respectively. Conclusion. Insufficient postvaccinal (humoral) immunity against pertussis was revealed in majority of children under 7 years. The ratio of such children decreases with age. It suggests the presence of hidden circulation of Bordetella pertussis and, as a result, previous medical condition in erased or abortive form.

1.

2. Vasyunina AV, Krasnova EI, Panasenko LM. Koklyush u detei. Lechaschi Vrach Journal. 2011;(10):55-60. (In Russ).

3. O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya nasel eniya v Rossiiskoi Federatsii v 2018 godu: Gosudarstvennyi doklad. Moscow: Federal'naya sluzhba po nadzoru v sfere zash-chity prav potrebitelei i blagopoluchiya cheloveka; 2019. 254 p. (In Russ). Доступно по: https://www.rospotrebnadzor.ru/upload/iblock/798/gosudarstvennyy-doklad-o-sostoyanii-sanitarno_epidemiologicheskogo-blagopoluchiya-naseleniya-v-rossiyskoy-federatsii-v-2018-godu.pdf. Ссылка активна на 18.01.2021.

4. Immunization coverage: WHO Fact sheet. July 15, 2019. (In Russ). Доступно по: https://www.who.int/ru/news-room/fact-sheets/detail/immunization-coverage. Ссылка активна на 15.08.2019.

5. Order № 125n Ministry Of Health Russia “Ob utverzhdenii regional'nogo kalendarya profilakticheskikh privivok i kalendarya profilakticheskikh privivok po epidemicheskim pokazaniyam” s izm. v sootvetstvii s Prikazom № 370n ot 16 iyunya 2016 g, Prikazom № 175n ot 13 aprelya 2017 g. “O vnesenii izmeneniy v prilozheniya №№ 1 i 2 k Prikazu ot 21 marta № 125n”; dated 2014 March 21. (In Russ). Доступно по: http://docs.cntd.ru/document/556673604. Ссылка активна на 15.08.2019.

6. Organizatsiya i provedenie sero-logicheskogo monitoringa sostoyaniya kollektivnogo immuniteta k infektsiyam, upravlyaemym sredstvami spetsificheskoi profilaktiki (difteriya, stolbnyak, koklyush, kor', krasnukha, epidemicheskii parotit, poliomielit, gepatit V). Metodicheskie ukazaniya MU 3.1.2943-11. Moscow: Rospotrebnadzor; 2011. (In Russ). Доступно по: http://docs.cntd.ru/document/1200088401. Ссылка активна на 15.08.2019.

7. Instruktsiya po primeneniyu vaktsiny koklyushno-difteriino-stolbnyachnoi adsorbirovannoi zhidkoi (AKDS-vaktsiny). (In Russ). Доступно по: http://old.gsen.ru/infections/directions/akds.pdf. Ссылка активна на 21.05.2020.

8. Fedoseenko MV, Galitskaya MG, Gayvoronskaya AG, Stepanov AA. Safety of acellular pertussis vaccine for children older than four years. Medical News of North Caucasus. 2010;19(3):69-70. (In Russ).

9. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24(5 Suppl):S58-S61. doi: 10.1097/01.inf.0000160914.59160.41

10. Nicolaeva IV, Shaikhieva GS. Pertussis at the present stage. The Bulletin of Contemporary Clinical Medicine. 2016;9(2):25-29. (In Russ). doi: 10.20969/VSKM.2016.9(2).25-29

11. Basov AA. Epidemicheskii protsess koklyusha na sovremennom etape. [abstract of dissertation]. Moscow; 2016. (In Russ).

12. Forsyth KD, von Konig C-HW, Tan T, et al. Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine. 2007;25(14):2634-2642. doi: 10.1016/j.vaccine.2006.12.017.

13. Forsyth KD, Campins-Marti M, Caro J, et al. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. Clin Infect Dis. 2004;39(12):1802-1809. doi: 10.1086/426020

14. Guiso N, Liese J, Plotkin S. The Global Pertussis Initiative: meeting report from the fourth regional roundtable meeting, France, April 14-15, 2010. Hum Vaccin. 2011;7(4):481-488. doi: 10.4161/hv.7.4.14528

15. Zepp F, Heininger U, Mertsola J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis. 2011;11(7):557-570. doi: 10.1016/S1473-3099(11)70007-X

16. Pertussis vaccines: WHO position paper — August 2015. Weekly epidemiological record. 2015;90(35):433-460.

17. Tatochenko VK. Pertussis — Infection not under Complete Control. Voprosy sovremennoi pediatrii — Current Pediatrics. 2014; 13(2):78-82. (In Russ). doi: 10.15690/vsp.v13i2.975

18. Timofeeva TV, Googe EG, Fatina NM. Post-vaccination immunity to pertussis in children of lipetsk, new management capabilities to infection. Epidemiology and Vaccinal Prevention. 2019;18(3):60-64. (In Russ). doi: 10.31631/20733046-2019-18-3-60-64

19. Basov AA, Tsvirkun OV, Gerasimova AG, et al. Condition of specific immunity to pertussis in different age groups of children. Epidemiology and Vaccinal Prevention. 2015;14(3):84-88. (In Russ). doi: 10.31631/20733046-2015-14-3-84-88

20. Kurova NN, Tseneva GYa, Zhebrun AB. Anti-pertussis immunity in children in the cities of northwestern federal district with various population. Zhurnal mikrobiologii, epidemiologii i immunobiologii = Journal of Microbiology, Epidemiology and Immunobiology. 2013;(4):33-37. (In Russ).

21. Hafler JP, Pohl-Koppe A. The cellular immune response to Borde-tella pertussis in two children with whooping cough. Eur J Med Res. 1998;3(11):523-526.

22. Popova OP. Koklyush u detei: kliniko-immunologicheskie aspekty, diagnostika i lechenie. [abstract of dissertation]. Moscow; 2014. 45 p. (In Russ).

23. Kurova N, Timofeeva EV, Guiso N, Macina D. A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia. Vaccine. 2018;36(52):7936-7942. doi: 10.1016/j.vaccine.2018.11.007